Skip to main content
Premium Trial:

Request an Annual Quote

Biosis,TheScientificWorld,Weizmann Institute, Genops Bioinformatics

Premium

Biosis, a Philadelphia-based non-profit organization that accumulates and organizes abstracts and bibliographic references to biomedical literature, has collaborated with TheScientificWorld of Boynton Beach, Fla., to launch methodsBase, a research tool available through www.thescientificworld.com. The tool features links to full-text journal articles, patents, and services for procuring laboratory and biological resources.

Updated weekly, methodsBase currently performs free-text searches on more than 175,000 classified and indexed records selected from scientific journals, books, conference proceedings, patents, protocols, and websites.

 

Israel’s Weizmann Institute has made version 2.23 of the GeneCards database of human genes available at http://bioinformatics.weizmann.ac.il/cards.

The latest release includes 27,612 genes and 51 gene clusters, an expanded SNPs section, and gene description information for C. elegans homologs.

 

Genops Bioinformatics has ported its sequence analysis platform, Ngene, to Mac OS X and has added an evaluation version to the Windows-based trial already available from www.genops.com/down- load/default.htm.

 

Filed under

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.